The store will not work correctly when cookies are disabled.
5-((naphthalen-1-ylamino)methyl)pyrimidine-2,4-diamine
ID: ALA1097863
PubChem CID: 46888182
Max Phase: Preclinical
Molecular Formula: C15H15N5
Molecular Weight: 265.32
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Nc1ncc(CNc2cccc3ccccc23)c(N)n1
Standard InChI: InChI=1S/C15H15N5/c16-14-11(9-19-15(17)20-14)8-18-13-7-3-5-10-4-1-2-6-12(10)13/h1-7,9,18H,8H2,(H4,16,17,19,20)
Standard InChI Key: YKFNVUKRKLDESS-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 22 0 0 0 0 0 0 0 0999 V2000
4.2494 -6.2240 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.2482 -7.0523 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9640 -7.4657 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.6812 -7.0518 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6783 -6.2204 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9622 -5.8108 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5326 -7.4647 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.9597 -4.9848 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.3922 -5.8047 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1090 -6.2149 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.8227 -5.7993 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2486 -4.9712 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5267 -4.5611 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8164 -4.9784 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2512 -5.7981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5402 -6.2101 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5426 -7.0302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2553 -7.4390 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9672 -7.0218 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9613 -6.2031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9 10 1 0
2 3 1 0
10 11 1 0
11 16 2 0
5 6 2 0
15 12 2 0
6 1 1 0
12 13 1 0
1 2 2 0
13 14 2 0
14 11 1 0
2 7 1 0
3 4 2 0
15 16 1 0
6 8 1 0
16 17 1 0
17 18 2 0
5 9 1 0
18 19 1 0
4 5 1 0
19 20 2 0
20 15 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 265.32 | Molecular Weight (Monoisotopic): 265.1327 | AlogP: 2.41 | #Rotatable Bonds: 3 |
Polar Surface Area: 89.85 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 7.23 | CX LogP: 1.85 | CX LogD: 1.64 |
Aromatic Rings: 3 | Heavy Atoms: 20 | QED Weighted: 0.68 | Np Likeness Score: -0.92 |
References
1. Bag S, Tawari NR, Degani MS, Queener SF.. (2010) Design, synthesis, biological evaluation and computational investigation of novel inhibitors of dihydrofolate reductase of opportunistic pathogens., 18 (9): [PMID:20363634] [10.1016/j.bmc.2010.03.031] |